Angrety S. B. Stefanie K. Claudia I. Felix Hansen Juni Ray B. Charisa Lazarus Jason A. S. 1010030 1010095 1010003 1010101 1010070 1010140 1010093 1010074
Pro sel NK
makrofag
fagositosis
Cortex Cortex luar : nodulus limfatikus (sel B, sel retikular, sel dendritik, serat retikular) Cortex dalam (zona paracortex): jaringan limfoid padat (sel T) Medulla Terdapat Medullary cord yaitu jaringan limfoid yang tersusun di sekitar pembuluh darah. Hillus : arteri, vena, saraf, p.limfe P.L. aferen sinus subkapsularis sinus trabekularis sinus medularis P.L. eferen
Imunogenitas Tumor
Immunologi tumor
Pertumbuhan sel kanker ditentukan oleh kemampuan sel kanker berproliferasi dan kemampuannya menghindari respon imun (immune surveillance) Sel kanker akan mengekspresikan antigen permukaan yg khas dan seringkali memicu respon imun.
Imunogenitas tumor
Imunogenitas tumor sangat tergantung pada bagaimana tumor itu terbentuk. Tumor akibat karsinogen dan infeksi virus bersifat imunogenik. Tumor akibat mutasi (delesi,translokasi,insersi gen virus) sifat imunogenitasnya rendah.
Sel NK mempunyai 2 reseptor: KARs dan KIRs dimana aktivasi KARs dihambat o/ KIRs Pada sel kanker, ekspresi MHC1 seringkali menurun bahkan tidak diekspresikan, maka tidak ada yg menghambat aktivasi KARs dan terjadilah lisis sel target Salah satu kompleks reseptor aktivasi pada sel NK adalah reseptor NKG2D (sbg reseptor aktivasi primer, dpt mengatasi inhibisi o/ ikatan KIRs dg MHC1)
ONKOGENESIS
Tumor
Pertumbuhan tumor terjadi karena mutasi dari 4 jenis gen: Gen yang memperngaruhi pertumbuhan sel ( proto-oncogenes dan tumor suppressor genes) Gen yang mengatur apoptosis Gen yang mengatur perbaikan DNA
Memenuhi kebutuhan growth factor Penurunan sensitivitas terhadap growth inhibitory signal Menghindar dari apoptosis Kapasitas untuk membelah terus Membentuk vaskularisasi baru Kemampuan metastasis
Siklus sel
Etiology
- Unknown, the abnormal cell may be triggered by an infection or expossure to something in the environment. - NHLs may result from chromosomal translocations, environmental factors, immunodeficiency states, and chronic inflammation.
www.cancer.org ; www.emedicinehealth.com
Risk Factors
Older age Gender (men>women) Rase,ethnicity,geography Exposure to certain chemicals Radiation Exposure Immune system deficiency Autoimmune diseases Infection (viruses, bacteria)
www.cancer.org ; www.emedicinehealth.com
Working Formulation
Low Grade Small lymphocytic Intermediate Grade Follicular large cell High Grade Large cell immunoblastic Lymphoblastic Small non-cleaved cell (Burkitt and non-Burkitt type)
T-Cell and Natural Killer Cell Neoplasms I. Precursor T cell neoplasm: Precursor T-lymphoblastic lymphoma/leukemia II. Mature (peripheral) T cell and NK-cell neoplasms A. T cell prolymphocytic leukemia B. T-cell granular lymphocytic leukemia C. Aggressive NK-Cell leukemia D. Adult T cell lymphoma/leukemia (HTLV1+) E. Extranodal NK/T-cell lymphoma, nasal type F. Enteropathy-type T-cell lymphoma G. Hepatosplenic gamma-delta T-cell lymphoma H. Subcutaneous panniculitis-like T-cell lymphoma I. Mycosis fungoides/Szary's syndrome J. Anaplastic large cell lymphoma, T/null cell, primary cutaneous type K. Peripheral T cell lymphoma, not otherwise characterized L. Angioimmunoblastic T cell lymphoma M. Anaplastic large cell lymphoma, T/null cell, primary systemic type
Hodgkin lymphoma Nodular lymphocyte predominance Hodgkin's lymphoma Classical Hodgkin's lymphoma
Nodular sclerosis Hodgkin's lymphoma Lymphocyte-rich classical Hodgkin's lymphoma Mixed cellularity Hodgkin's lymphoma Lymphocyte depletion Hodgkin's lymphoma
III
IV
Jika mengenai 1 organ extralimfatik / lebih tetapi secara difus dengan atau tanpa melibatkan limfatik
Semua stadium dibagi berdasarkan ada atau tidaknya gejala sistemik : demam, keringat malam, hilangya berat badan lebih dari 10% berat normal (jika terdapat gejala sistemik tersebut beri huruf B, jika tidak ada beri huruf A)
Patogenesis
Genetic Virus : HTLV-1, EBV, KSHV/HHV-8 Chronic Immune Stimulation Iatrogenic : radiation, chemotherapy Smoking : benzene AML
Patofisiologi + GK
Mass (DLCBL) : rapidly enlarging mass at nodal or extranodal Cancer Cachexia (weakness, anorexia, anemia, weight loss) BMR cytokine: tumor and host (TNF, IL-1, interferon-) soluble factors produced by tumors proteolysis, lipid mobilizing, catabolism homeostatic change
Erosive, Infiltrative hematochezia, constipation, abdominal pain Febris : cytokine Sweating : febris compensation
Komplikasi
GIT
Perdarahan Infeksi Peritonitis
Terapi
Gagal ginjal Kerusakan hepar Keganasan
Leher
Thyroid, parathyroid Jalan nafas
Diagnosis Dasar
Bpk L, 54thn (FR60Y) KU: benjolan RLQ 2bln yll, makin membesar (sus. neoplasia, lymphadenopathy, lymphadenitis) Sjk 1 bln: benjolan di leher, febris hilang timbul (febris recurrens), srg berkeringat mlm hr (night sweat) (sus. Lymphadenitis TB, lymphoma) 1 mgg terakhir: nyeri terus menerus (continua) seluruh (difus) bag.perut, benjolan leher x nyeri
X bertani krn malaise, anorexia, nausea, kad vomitus (GK sistemik) Sejak 6bln: BB menurun ~10kg (sus. Lymphadenitis TB, lymphoma) BAB agak sulit & lbh jarang (konstipasi), kad.hematochezia R.Kebiasaan: merokok sjk muda & pekerjaan srg pakai pestisida (FR u/ NHL) Respirasi: 24x/min (batas atas) Suhu: 380C (febris)
Pemeriksaan Fisik
KU: CM , tampak kesakitan Kepala : conjunctiva anemis +/+ (krn hematochezia, mgkn kronis) Leher: teraba masa a/r coli dextra, 2X1,5cm, oval, soliter, batas tegas, permukaan licin, nyeri tekan(-), terfiksasi, tidak ikut bergerak ketika menelan, tdk tampak tanda2 radang. (sus. Neoplasia) Abdomen: Perkusi: dull(+) RUQ & LUQ (krn ada masa) Palpasi: nyeri tekan slrh Q, defance muscular(+), benjolan di RUQ x jls teraba
Pem Lab:
SGOT & SGPT (): fx hepar BUN & Creatinine (): fx hepar
LDH: dbn Hb():Anemia As.urat (): Hyperuricemia Ht(): Anemia B2M (): WBC(): Leukositosis MM/leukemia/lymphoma LED(): inflamasi CEA (): mgkn krn perokok Diff count Limfositosis berat SADT: mgkn infeksi berat CA 19-9: N
CT scan abd: Tampak dinding ileum yg menebal di slrh bag yg memberikan gbrn hipodens yg berbatasan dgn cairan kontras dgn ketebalan s/ 5,2cm hingga 7,45cm yg menimbulkan penyempitan lumen ileum serta tampak mukosa iregular. Tampak adanya masa nodular di kanan yg memberikan enhancement post pemberian kontras dgn ukuran 6,5 x 5 x 4,4 cm
Biopsi kgb coli dextra: Diffuse Non Hodgkins Lymphoma Lymphocytic Type (Low Grade Lymphoma)
DK: Diffuse Non Hodgkins Lymphoma Lymphocytic Type (Low Grade Lymphoma) + Anemia ringan + Hyperuricemia
Pem. Penunjang
Pem. hematologi rutin Hb, Ht Leukosit, trombosit hitung jenis LED SADT Pem. fungsi hepar: SGOT, SGPT Pem.fungsi ginjal: BUN, Creatinine Pem.elektrolit: Na, K, Mg, Ca Asam urat Tumor marker: CEA, CA 19-9, B2M LDH Beta-2 microglobulin
CT Scan (thorax, abdomen, pelvis) PET Scan MRI Chest Xray Biopsy Immunophenotyping Lymphangiogram Gallium scan
TREATMENT
Depends on : The type of non-Hodgkin's lymphoma Its stage How quickly the cancer is growing The patient's age Whether the patient has other health problems If there are symptoms present (fever and night sweats)
1. Chemotherapy
A drug treatment either as an injection or oral form that kills cancer cells Can involve one medication or multiple medications and be given alone or in conjunction with other therapies
2. Radiation therapy
High doses of radiation are used to kill cancer cells and shrink tumors This modality can be used alone or in conjunction with other therapies
4. Biological drugs
Medications that enhance immune system's ability to fight cancers In NHL, monoclonal antibodies are used for treatment Rituximab (Rituxan) is such a drug used in the treatment of B cell lymphoma
PROGNOSIS
Umur
Stage Lokasi Performans stat.
< 60 thn
I/ II No outside Aktivitas (N)
> 60 thn
III/ IV > 1 limfoma di luar Lymph node Tdk bisa / susah beraktivitas
LDH
LDH (N)
LDH meningkat
1 risk factor : low risk, 5 years lymphoma survival rate 70 % 2-3 risk factor: Intermediate risk , 5 years lymphoma survival rate 48-50 % 4-5 risk factor: High risk, 5 years lymphoma survival rate 26 %